PL3727397T3 - Kompozycja i sposób leczenia, łagodzenia lub zapobiegania bólowi neuropatycznemu, zawierająca alfosceran choliny jako substancję czynną - Google Patents

Kompozycja i sposób leczenia, łagodzenia lub zapobiegania bólowi neuropatycznemu, zawierająca alfosceran choliny jako substancję czynną

Info

Publication number
PL3727397T3
PL3727397T3 PL18891192.9T PL18891192T PL3727397T3 PL 3727397 T3 PL3727397 T3 PL 3727397T3 PL 18891192 T PL18891192 T PL 18891192T PL 3727397 T3 PL3727397 T3 PL 3727397T3
Authority
PL
Poland
Prior art keywords
relieving
treating
composition
active ingredient
neuropathic pain
Prior art date
Application number
PL18891192.9T
Other languages
English (en)
Inventor
Kweon Haeng Lee
Jun-Ho Yeo
Young Lim
Kunik Lee
So Hee Hyun
Original Assignee
Hub Washington Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hub Washington Inc filed Critical Hub Washington Inc
Publication of PL3727397T3 publication Critical patent/PL3727397T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
PL18891192.9T 2017-12-19 2018-12-10 Kompozycja i sposób leczenia, łagodzenia lub zapobiegania bólowi neuropatycznemu, zawierająca alfosceran choliny jako substancję czynną PL3727397T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170174814A KR101841654B1 (ko) 2017-12-19 2017-12-19 콜린 알포세레이트를 유효성분으로 하는 신경병증성 통증의 치료, 개선 또는 예방용 조성물 및 방법
PCT/KR2018/015621 WO2019124842A1 (en) 2017-12-19 2018-12-10 Composition and method for treating, relieving or preventing neuropathic pain, containing choline alfoscerate as active ingredient

Publications (1)

Publication Number Publication Date
PL3727397T3 true PL3727397T3 (pl) 2023-08-07

Family

ID=61910873

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18891192.9T PL3727397T3 (pl) 2017-12-19 2018-12-10 Kompozycja i sposób leczenia, łagodzenia lub zapobiegania bólowi neuropatycznemu, zawierająca alfosceran choliny jako substancję czynną

Country Status (7)

Country Link
US (1) US11311561B2 (pl)
EP (1) EP3727397B1 (pl)
JP (1) JP7100784B2 (pl)
KR (1) KR101841654B1 (pl)
ES (1) ES2949267T3 (pl)
PL (1) PL3727397T3 (pl)
WO (1) WO2019124842A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101864384B1 (ko) * 2017-12-11 2018-06-04 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 쥐남의 치료, 개선 또는 예방용 조성물 및 방법
KR101841654B1 (ko) * 2017-12-19 2018-03-26 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 신경병증성 통증의 치료, 개선 또는 예방용 조성물 및 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199972B (it) 1985-05-08 1989-01-05 Lpb Ist Farm Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20090176740A1 (en) * 2007-11-30 2009-07-09 Phillips Ii Dauglas James Treatment of neurological conditions by the co-administration of aniracetam and l-alpha glycerylphosphorylcholine
KR101499533B1 (ko) * 2008-02-15 2015-03-09 주식회사 씨티씨바이오 콜린 알포세레이트 함유 약학 제제
KR101179470B1 (ko) * 2010-03-23 2012-09-07 (주)비씨월드제약 라세믹체, D체 또는 L-α-글리세릴 포스포릴콜린의 신규한 제조방법
JP2012162473A (ja) * 2011-02-04 2012-08-30 Takeshi Matsuzaki N−アセチルグルコサミンを含有する組成物
KR101257919B1 (ko) * 2011-07-14 2013-04-30 주식회사 바이오파마티스 콜린 알포세레이트 또는 이의 약학적으로 허용되는 염을 포함하는 경구용 고형 제제 및 이의 제조방법
US9408846B2 (en) 2012-04-23 2016-08-09 The Children's Medical Center Corporation Formulations and methods for delaying onset of chronic neuropathic pain
KR102008490B1 (ko) * 2013-01-14 2019-08-08 주식회사 바이오파마티스 콜린 알포세레이트 또는 이의 약학적으로 허용되는 염을 포함하는 방출 조절형 약학 조성물 및 이의 제조방법
WO2014160423A1 (en) 2013-03-13 2014-10-02 Genetic Disease Investigators, LLC Methods and compositions for correction of organ dysfunction
JP2015007002A (ja) * 2013-06-24 2015-01-15 日油株式会社 ロコモティブ症候群改善剤
KR101628937B1 (ko) * 2014-11-06 2016-06-09 환인제약 주식회사 콜린알포세레이트를 함유하는 정제 및 그 제조방법
KR101833800B1 (ko) 2014-12-19 2018-03-02 삼성에스디아이 주식회사 실리카계 막 형성용 조성물, 실리카계 막의 제조방법 및 상기 실리카계 막을 포함하는 전자 소자
KR101865914B1 (ko) * 2016-02-25 2018-06-12 오명진 지방분해 및 셀룰라이트 개선 성분을 함유하는 다이어트 주사용 조성물
JP6762007B2 (ja) * 2016-06-14 2020-09-30 国立大学法人広島大学 変形性関節症予防用組成物、変形性関節症予防用食品組成物、変形性関節症予防用食品添加物及び変形性関節症予防用医薬
KR101841654B1 (ko) 2017-12-19 2018-03-26 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 신경병증성 통증의 치료, 개선 또는 예방용 조성물 및 방법

Also Published As

Publication number Publication date
JP7100784B2 (ja) 2022-07-14
EP3727397B1 (en) 2023-06-07
JP2021507887A (ja) 2021-02-25
EP3727397A1 (en) 2020-10-28
EP3727397C0 (en) 2023-06-07
EP3727397A4 (en) 2021-09-01
WO2019124842A1 (en) 2019-06-27
US11311561B2 (en) 2022-04-26
US20200338099A1 (en) 2020-10-29
KR101841654B1 (ko) 2018-03-26
ES2949267T3 (es) 2023-09-27

Similar Documents

Publication Publication Date Title
ZA201908241B (en) N2,n4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer
SG11202013239RA (en) Composition and method for treating pain
GB2578539B (en) Compositions and methods for preventing or treating muscle conditions
PH12019502646A1 (en) Pyrazole magl inhibitors
WO2018039475A8 (en) Use of pridopidine for treating dystonias
EP3659611A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF OSTEOPOROSIS WITH EXOSOMES EXTRACTED FROM STEM CELLS AS THE ACTIVE SUBSTANCE
EP3266317A4 (en) Composition for preventing, improving or treating neurological disorders, containing osmotin peptide as active ingredient
SG11201709800RA (en) Composition for inhibiting and preventing myopathy, containing bean leaf extract as active ingredient
EP3295946A4 (en) Composition, containing lithospermi radix extract as active ingredient, for preventing, alleviating, or treating peripheral neuropathy
WO2016134257A8 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
EP3636281C0 (en) METHOD FOR TREATING DEPRESSION AND PHARMACEUTICAL COMPOSITION
IL268224A (en) A pharmaceutical compound for the prevention and treatment of pancreatic cancer, containing GOSSYPOL and PHENFORMIN as active ingredients
EP2982378A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK WITH ADK PROTEIN AS AN ACTIVE SUBSTANCE
GB2579480B (en) Composition for preventing or treating cancer containing Triazolopyridine-based derivative as active ingredient
ZA202007320B (en) Compounds for pain treatment, compositions comprising same, and methods of using same
PL3727397T3 (pl) Kompozycja i sposób leczenia, łagodzenia lub zapobiegania bólowi neuropatycznemu, zawierająca alfosceran choliny jako substancję czynną
EP3284464A4 (en) Composition for preventing and treating pancreatitis containing naphthoquinone-based compound as active ingredient
EP3723766A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT, MITIGATION OR PREVENTION OF MUSCLE CRAMPS, CONTAINING CHOLINE ALFOSCERATE AS ACTIVE INGREDIENT
ZA201904328B (en) Composition, application thereof and treatment method
GB202214988D0 (en) Compositions and methods for preventing or treating nephrolithiasis
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
ZA202000884B (en) Compositions for treating skin and mucous membrane infections
EP3260121A4 (en) Composition for preventing, alleviating or treating metabolic diseases, containing amodiaquine as active ingredient
EP3216452A4 (en) Composition for preventing or treating mucositis comprising necrox as effective ingredient
IL254793A0 (en) A compound for the treatment of neuropathic diseases and/or neuropathic pain